Aetion
Josh Stewart is an experienced business development professional with a strong background in the biopharmaceutical and healthcare sectors. Currently serving as Client Partner Lead at Aetion since July 2022, Josh previously held key roles at IQVIA, including Head of Business Development for BioFortis and Director of Business Development for Real World Solutions, where efforts focused on enhancing awareness and understanding of real-world data among large biopharmaceutical companies. Earlier positions at Johnson & Johnson encompassed District Sales Manager and Product Manager roles, with a record of exceeding sales targets. Josh's career also includes experiences at Medtronic and Merrill Lynch, complementing a solid educational foundation with an MBA from Vanderbilt University and a BS in Finance from Butler University.
This person is not in the org chart
This person is not in any offices
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.